Amryt Pharma (AMYT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Amryt Pharma

    NASDAQ: AMYT · Real-Time Price · USD
    14.70
    0.00 (0.00%)
    At close: Jan 16, 2025, 10:00 PM

    Amryt Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 222.54M
    Cost of Revenue
    		 106.12M
    Gross Profit
    		 116.42M
    Operating Income
    		 -21.64M
    Interest Income
    		 5K
    Pretax Income
    		 -29.81M
    Net Income
    		 -18.17M
    Selling & General & Admin
    		 100.34M
    Research & Development
    		 37.73M
    Other Expenses
    		 n/a
    Operating Expenses
    		 138.06M
    Interest Expense
    		 27.91M
    Selling & Marketing Expenses
    		 92M
    Cost & Expenses
    		 244.18M
    Income Tax Expense
    		 -11.64M
    Shares Outstanding (Basic)
    		 47.17M
    Shares Outstanding (Diluted)
    		 49.4M
    EPS (Basic)
    		 -0.39
    EPS (Diluted)
    		 -0.37
    EBITDA
    		 29.1M
    EBIT
    		 26M
    Depreciation & Amortization
    		 50.74M

    Add to Watchlist